Skip to main content
All lobbying filings

FORBES-TATE

Lobbying for IONIS PHARMACEUTICAL, INC. · Biopharmaceutical company developing RNA therapies.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $30,000.00 income · posted Apr 14, 2025

Official filing document

 Bills named in this filing 2
  • HR 5547
    Maintaining Investments in New Innovation Act
  • S 476
    Maintaining Investments in New Innovation Act
 Lobbying activity 2
Health Issues

Issues related to Creating Hope Act and issues related to H.R. 5547/S. 476 - Maintaining Investments in New Innovation.

Medicare/Medicaid

Issues related to Creating Hope Act & issues related to H.R. 5547/S. 476 - Maintaining Investment in New Innovation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem